Feed/Companies/CREATE Medicines

CREATE Medicines

As of 14 Oct 2026, CREATE Medicines has raised $122M across 1 verified round on record; latest: $122 million Series B led by Arch Venture Partners, Hatteras Venture Partners and 1 other, announced 14 May 2026.

BUILT ON

Visit site

Create Medicines develops innovative immune programming therapies for treating cancer and autoimmune diseases.

createmedicines.comLinkedIn

LATEST ROUND

Series B

$122M · 2026-05-14

RAISED ON RECORD · USD

$122M

across 1 verified round

INVESTORS

3 leads

SOURCES

from 2 publishers

Rounds

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series B

$122M · 2026-05-14

[ HISTORY ]

led by Arch Venture Partners, Hatteras Venture Partners, Newpath Partners

Round	Amount	Announced	Lead	Buzz
Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$122M	2026-05-14	Arch Venture Partners, Hatteras Venture Partners, Newpath Partners	No recent discussion
2 sources [ VERIFIED ] read against 2 sources

CREATE Medicines

Rounds

Company

Rounds

Sources

Profile

Investors

CREATE Medicines

Rounds

Profile

Sources

Series B$122M2026-05-142 sources

Investors

Series B$122M2026-05-144 investors